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Abstract 16 
The adiponectin axis regulates cardiometabolic and inflammatory tone making it an attractive 17 
therapeutic focus.  Rudimentary understanding of the adiponectin receptors, AdipoR1 and 18 
AdipoR2, constrains our ability to target these atypical seven trans-membrane proteins.  Here, 19 
we aimed to further elaborate the molecular details governing cell-surface expression and 20 
signal transduction by transient expression of AdipoR1 or AdipoR2 in HEK293 cells.  21 
Following serum starvation, adiponectin reduced cell-surface expression of both receptors, 22 
consistent with internalisation, and promoted phosphorylation of downstream effectors.  23 
Temporal phosphorylation profiles differed with AdipoR1 and AdipoR2 transduced signals 24 
peaking at 15 min and 24 h.  Analysis of receptor chimeras showed that the non-conserved N-25 
terminal trunks (AdipoR1(1-70) and AdipoR2(1-81)) define the temporal signalling profiles and 26 
contain multiple regions that promote or inhibit cell-surface expression, respectively.  These 27 
findings highlight the importance of the non-conserved N-terminal trunks and demonstrate 28 
that cell-surface expression of AdipoR1 and AdipoR2 is required for effective coupling to 29 
downstream effectors. 30 
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1.  Introduction 34 
Adiponectin is a key adipokine with demonstrated anti-diabetic, anti-inflammatory and anti-35 
atherogenic properties (Scherer, 2006).  Adiponectin’s pleiotropic effects are mediated 36 
through two atypical 7 transmembrane (7TM) domain receptors termed AdipoR1 and AdipoR2 37 
(Hickman and Whitehead, 2012; Yamauchi et al., 2003).  Empirical evidence demonstrates that 38 
AdipoR1 and AdipoR2 have intracellular N-termini and extracellular C-termini (Yamauchi et al., 39 
2003) unlike most other 7TM proteins including the G-protein coupled receptors (GPCRs).  In 40 
vivo and in vitro studies have demonstrated that AdipoR1 and AdipoR2 mediate the effects of 41 
adiponectin via activation of a number of signalling molecules such as AMPK, PPARα, ERK 42 
and P38MAPK (Cong et al., 2007; Deepa and Dong, 2009; Shibata et al., 2005; Wijesekara et 43 
al., 2010; Yamauchi et al., 2007).  Coupling to these downstream effectors has been shown to 44 
be modulated by proteins that interact with the cytoplasmic, N-terminal domains of both 45 
AdipoR1 and AdipoR2, such as APPL1, RACK and protein kinase CK2 (Deepa and Dong, 46 
2009; Heiker et al., 2009; Xu et al., 2009), or with the non-conserved N-terminal trunk of 47 
AdipoR1, namely ERp46 (Charlton et al., 2010).   48 
Emerging evidence indicates that obesity-related diseases are characterised not only by 49 
hypoadiponectinemia but also by adiponectin resistance at the level of the adiponectin 50 
receptors (Bruce et al., 2005; Chen et al., 2005; Kintscher, 2007; Lara-Castro et al., 2008; 51 
Mullen et al., 2007; Rodríguez et al., 2008).  Thus, a greater understanding of the molecular 52 
processes required to facilitate efficient adiponectin receptor coupling to intracellular 53 
signalling pathways may be expected to provide new insights into pathophysiological events 54 
and the identification of novel therapeutic approaches.   55 
We recently reported that under steady-state conditions (no serum starvation) the cell-surface 56 
expression of AdipoR1 and AdipoR2 differs.  AdipoR1 is enriched in the plasma membrane 57 
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whilst AdipoR2 is more abundant in the ER (Keshvari et al., 2013).  We also demonstrated 58 
that this difference is due to the non-conserved N-terminal trunks of AdipoR1 and AdipoR2 59 
(Keshvari et al., 2013).  In the current report we have extended these studies by performing 60 
further characterisation of the molecular features governing the cell-surface expression and 61 
subsequent coupling to downstream signalling effectors of AdipoR1 and AdipoR2.  Our 62 
results demonstrate that the non-conserved N-terminal trunks dictate the cell-surface 63 
expression and temporal signalling profiles of AdipoR1 and AdipoR2. 64 
2.  Materials and methods 65 
2.1.  Reagents and antibodies 66 
Reagents were from Sigma–Aldrich (Castle Hill, Australia) unless otherwise stated.  Tissue 67 
culture reagents were from Invitrogen (Mount Waverley, Australia).  Primary antibodies 68 
against HA and Sodium Potassium ATPase were from Covance (Washington, USA)  and 69 
Abcam (Melbourne, Australia) respectively.  Primary antibodies against AdipoR1 and 70 
AdipoR2 were as described (Charlton et al., 2010).  Secondary antibodies were from Life 71 
Technology (Invitrogen).  Molecular biology reagents were from New England Biolabs 72 
(Ipswich, NA, USA) or Promega Corporation (Madison, WA, USA).  Serum from adult WT 73 
and adiponectin knockout mice (Maeda et al., 2002) was collected in accordance with ethics 74 
approval from the animal ethics committee of the University of Queensland. 75 
2.2.  Molecular biology 76 
Original constructs encoding C-terminally epitope-tagged (HA) human AdipoR1 and 77 
AdipoR2 were as described (Charlton et al., 2010).  Chimeric and truncated receptor 78 
constructs were generated as described (Keshvari et al., 2013).  AdipoR1 and AdipoR2 79 
mutants were generated by QuikChange site-directed mutagenesis (Agilent Technology, CA, 80 
USA).  Mutations were confirmed by DNA sequencing (Sanger method).  Chinese Hamster 81 
Ovary (CHO) cells or Human Embryonic Kidney 293 (HEK293) cells were transfected using 82 
Lipofectamine PLUS (Invitrogen) according to the manufacturer’s instructions.  Transfection 83 
efficiency was typically around 70% and cells were analysed 24-48 h post-transfection.   84 
2.3.  Flow cytometry analysis 85 
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Flow cytometry was performed to determine the percentage of transfected cells that were 86 
expressing AdipoR1 or AdipoR2 at the cell-surface.  Flow cytometry was carried out using a 87 
CyAn™ ADP Analyser (Beckman Coulter, Sydney, Australia) and FlowJo software.  Briefly, 88 
HEK293 cells were washed with cold PBS and stained with HA antibody.  For analysis of 89 
permeabilised cells, cells were incubated in 0.1% Saponin for 15 min prior to blocking.  After 90 
washing with PBS, cells were stained with an AlexaFluor 488-conjugated secondary antibody 91 
(Invitrogen).  Cells were then lifted non-enzymatically and 80,000 events were analysed by 92 
flow cytometer.  For all experiments, mean fluorescence intensity (MFI) values were 93 
calculated by subtracting secondary only staining from specific anti-HA staining.   94 
2.4.  Plate-based determination of cell-surface expression of AdipoR1 and AdipoR2 95 
Quantitative measurement of total and cell-surface expression of AdipoR1 and AdipoR2 was 96 
performed, in permeabilised and non-permeabilised cells respectively, using a plate-based 97 
assay as described (Keshvari et al., 2013).  Briefly, parental HEK293 cells or transfected 98 
HEK293 cells were incubated in either the presence or absence of serum at 37°C overnight.  99 
Cells were incubated in 100% ice-cold methanol for 5 min to permeabilise (for measurement 100 
of total receptor levels) or left non-permeabilised (for determination of receptors at the cell-101 
surface).  Cells were then stained with HA antibody followed by fixation with 4% 102 
Paraformaldehyde.  Cells were stained with an AlexaFluor 488-conjugated secondary 103 
antibody.  Signals were detected using the POLARstar Omega plate-reader (BMG Labtech, 104 
Offenburg, Germany).    105 
2.5.  Immunofluorescence microscopy 106 
Immunofluorescence microscopy of permeabilised and non-permeabilised cells was 107 
performed as described (Keshvari et al., 2013) affording details of the subcellular distribution  108 
of the receptors and the cell-surface expression respectively.  Images were taken using a 109 
Delta Vision OMX microscope (Applied Precision, GE Healthcare, Washington, USA).   110 
2.6.  Akt, ERK and p38MAPK phosphorylation assays 111 
Parental HEK293 cells or transfected HEK293 cells were serum-starved overnight then 112 
stimulated with recombinant human globular adiponectin (Prospec Protein Specialists, USA) 113 
or vehicle for 15 min, 1 h or 24 h.  Phosphorylation of Akt, ERK and p38MAPK was 114 
measured using AlphaScreen SureFire kits essentially as described (PerkinElmer Life and 115 
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Analytical Sciences, Waltham, MA, USA).  Plates were read using a POLARstar Omega 116 
plate reader.  Background signals were determined by treatment of cells with the Akt1/2 117 
kinase inhibitor, U0126 (ERK inhibitor) or SB203580 (p38MAPK inhibitor) and were 118 
subtracted to give specific phospho-signals for Akt, ERK and p38MAPK respectively. 119 
2.7.  SDS-PAGE/Western blotting of AdipoR1 and AdipoR2 120 
Western blotting of particulate fractions (enriched for the ER and PM that contain greater 121 
than 90% of total cellular AdipoR1 and AdipoR2) was performed on parental and transfected 122 
cells as described (Charlton et al., 2010). 123 
2.8.  Statistical analysis 124 
Data are presented as mean ± SEM.  Significance was determined using one way ANOVA 125 
followed by Tukeys test with statistical significance defined as p < 0.05. 126 
3.  Results 127 
3.1.  Serum starvation increases the cell-surface expression of AdipoR1 and AdipoR2. 128 
We previously reported that under steady-state conditions the subcellular localisation of 129 
AdipoR1 and AdipoR2 differed with around 50% of AdipoR1 present on the cell-surface 130 
whilst AdipoR2 was localised predominantly at the ER (Keshvari et al., 2013).  We 131 
subsequently demonstrated that the non-conserved, N-terminal trunks of AdipoR1(1-70) and 132 
AdipoR2(1-81) underpinned these differences (Keshvari et al., 2013).  To extend these studies 133 
we first examined the cell-surface expression of transiently expressed, C-terminally HA-134 
tagged AdipoR1 and AdipoR2 (Keshvari et al., 2013) in serum-starved or non-starved HEK 135 
cells using flow cytometry and plate-based assays as well as high resolution microscopy.  136 
Flow cytometry was used to determine the number of cells with detectable cell-surface 137 
expression of AdipoR1 or AdipoR2.  Serum starvation did not affect the number of cells with 138 
AdipoR1 on the cell-surface however the number of cells with detectable cell-surface 139 
expression of AdipoR2 was significantly increased following serum starvation (Fig1A).  A 140 
complementary plate-based assay was used to determine total and cell-surface levels of 141 
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AdipoR1 and AdipoR2.  This approach revealed significantly increased cell-surface 142 
expression of both AdipoR1 and AdipoR2 following serum starvation (Fig 1B).  Finally, 143 
qualitative analysis by high resolution confocal microscopy suggested that the cell-surface 144 
expression of AdipoR1 was increased in cells following serum starvation.  We were unable to 145 
detect cell-surface expression of AdipoR2 in non-permeabilised cells in steady-state or 146 
serum-starved cells which probably reflects a limitation of this approach (Fig 1G-J).  These 147 
results extend our previous findings (Keshvari et al., 2013) by showing that serum starvation 148 
results in an increase in the proportion of AdipoR1 or AdipoR2 that is expressed on the cell-149 
surface with the latter resulting in an increase in the number of cells with detectable cell-150 
surface levels of AdipoR2.   Notwithstanding, the levels of AdipoR2 on the cell-surface of 151 
serum starved cells are still relatively limited compared to those of AdipoR1. 152 
3.2.  Adiponectin reduces cell-surface expression of AdipoR1 and AdipoR2. 153 
We next went on to investigate the effect of serum, and more specifically adiponectin, on  154 
receptor cell-surface expression.  Following overnight serum starvation cells overexpressing 155 
either AdipoR1 or AdipoR2 were incubated with 10% fetal bovine serum (FC) for 30, 60, 90, 156 
120 and 240 min.  Analysis by flow cytometry (Fig 2A-B) and microscopy (Fig 2C-J) 157 
indicated that cell-surface expression of both AdipoR1 and AdipoR2 was reduced by 60% 158 
and 90% after 30 min.  To investigate the role of adiponectin more specifically we then used 159 
serum from wild-type (WT) or adiponectin knockout (Adn-/-) mice.  Serum from WT mice 160 
promoted similar effects as the FC, whilst serum from Adn-/- mice was without effect (Fig 161 
2A-B).  Similar results were obtained following treatment with 2.5 µg/ml globular 162 
adiponectin (gAd) (Fig 2A-B).  These results are consistent with the adiponectin-mediated 163 
internalisation of AdipoR1 and AdipoR2 reported previously (Almabouada et al., 2013), and 164 
suggest this is a specific, ligand-mediated event. 165 
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3.3.  Overexpression of AdipoR1 and AdipoR2 enhances adiponectin stimulated Akt, ERK 166 
and P38MAPK phosphorylation. 167 
We next examined the effects of AdipoR1 and AdipoR2 overexpression on adiponectin-168 
stimulated phosphorylation of key signalling molecules implicated in mediating adiponectin’s 169 
effects, namely Akt (Cui et al., 2011; Wijesekara et al., 2010), ERK (Lee et al., 2008; 170 
Wijesekara et al., 2010) and P38MAPK (Charlton et al., 2010; Tang et al., 2007).  In the 171 
parental HEK293 cells endogenous levels of AdipoR1 and AdipoR2 were undetectable by 172 
standard Western blot whereas transfected AdipoR1 and AdipoR2 were readily detected (Fig 173 
3A & B).  Parental cells or cells overexpressing AdipoR1 or AdipoR2 were treated with 174 
recombinant gAd for 15 min or 24 h (based on preliminary timecourse experiments - data not 175 
shown) to determine acute and long-term effects.  Under these experimental conditions there 176 
was no detectable adiponectin-stimulated phosphorylation of Akt, ERK, or p38MAPK in the 177 
parental cells.  However, significant and maximal phosphorylation of Akt, ERK, and 178 
p38MAPK occurred after 15 min in AdipoR1 expressing cells, and after 24 h in AdipoR2 179 
overexpressing cells (Fig 3C-E).  We then went on to perform dose response studies, treating 180 
cells with increasing concentrations of gAd (0.5 – 5.0 µg/ml) for either 15 min or 24 h.  After 181 
15 min, the phospho-Akt dose response was similar in AdipoR1 and AdipoR2 overexpressing 182 
cells (Fig 3F), although AdipoR1 typically mediated 10-20% higher phosphorylation than 183 
AdipoR2.  However, after 24 h the phospho-Akt dose response was markedly different.  184 
AdipoR2 promoted robust Akt phosphorylation with as little as 0.5 µg/ml gAd whilst 185 
AdipoR1 was without effect at concentrations up to 1.5 µg/ml gAd (Fig 3I).  Coupling to 186 
ERK and p38 MAPK also showed different characteristics with AdipoR1 exhibiting greater 187 
transduction than AdipoR2 at 15 min, especially at gAd concentrations of 2.0 µg/ml or higher 188 
(Fig 3G & H).  These differences became less marked after 24 h (Fig 3J & K) with 189 
phosphorylation of P38MAPK being constitutively higher in AdipoR2 cells compared with 190 
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AdipoR1 cells (Fig 3K).  Collectively these results provide evidence that there are 191 
fundamental differences between signalling emanating from AdipoR1 and AdipoR2, most 192 
notably the difference in temporal profiles with AdipoR1 acting more acutely than AdipoR2. 193 
3.4.  The subcellular localisation of AdipoR1 and AdipoR2 is governed by multiple domains. 194 
We previously reported that the non-conserved N-terminal trunks of AdipoR1(1-70) and 195 
AdipoR2(1-81)  underpinned the observed differences in cell-surface expression (Keshvari et 196 
al., 2013).  To investigate this further we generated and characterised the cell-surface 197 
expression of a number of chimera (Fig 4A).  Analysis by flow cytometry demonstrated a 198 
striking profile, with increasing inclusion of the non-conserved trunk of AdipoR2 reducing 199 
cell-surface expression whilst the converse was observed upon increasing content of the non-200 
conserved trunk of AdipoR1 (Fig 4B).  These findings suggest there is not a single region or 201 
motif within the non-conserved trunks that underpins the different cell-surface expression 202 
profiles of AdipoR1 and AdipoR2 but that multiple regions contribute to these differences. 203 
Next we characterised the signalling properties of the two chimera in which the entire non-204 
conserved N-terminal trunks had been swapped (termed R1(70)R2 and R2(81)R1, respectively) 205 
(Fig 4A).  In cells overexpressing R2(81)R1 chimera the temporal profiles of Akt, ERK and 206 
p38MAPK phosphorylation showed peak phosphorylation at 24 h whereas in cells 207 
overexpressing R1(70)R2 chimera phosphorylation peaked at 15 min (Fig 4C-E).  These 208 
profiles closely resembled those of AdipoR2 and AdipoR1 respectively (see Fig 3A-C), 209 
indicating that key differences in the temporal signalling profiles of AdipoR1 and AdipoR2 210 
are dictated by the non-conserved N-terminal trunks.   211 
3.5.  Cell-surface expression and downstream signalling of AdipoR1 and AdipoR2 is 212 
regulated by conserved F(x)3F(x)3F and D(x)3LL motifs.   213 
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Two different motifs within the intracellular N-terminal trunk of AdipoR1 have been shown 214 
to be essential for its efficient cell-surface expression (Juhl et al., 2012).  Mutation of an 215 
acidic di-leucine motif (106D(x)3LL) or a putative ER exit motif (121F(x)3F(x)3F), which are 216 
known to regulate trafficking of GPCRs (Bermak et al., 2001; Schulein et al., 1998), resulted 217 
in inhibition of cell-surface expression of AdipoR1 (Juhl et al., 2012).  Alignment of the 218 
primary amino acid sequence of AdipoR1 and AdipoR2 from multiple species revealed 219 
conservation of these motifs between AdipoR1 and AdipoR2 (Fig 5A) leading us to speculate 220 
that these motifs would also be required for efficient cell-surface expression of AdipoR2.  To 221 
test this we generated and characterised the expression of AdipoR2, and AdipoR1, mutants in 222 
which the key residues were mutated to alanine (termed R1/R2-FFF or R1/2-DLL where each 223 
of the residues was mutated to A).  Flow cytometry of serum starved cells revealed a 224 
significant reduction in the cell-surface expression of AdipoR1-FFF and AdipoR1-DLL as 225 
well as AdipoR2-FFF and AdipoR2-DLL constructs compared to the WT receptors (Fig 5B 226 
& F).  Furthermore, these constructs exhibited reduced adiponectin-stimulated 227 
phosphorylation of Akt (Fig 5C&G), ERK (Fig 5D&H) and P38MAPK (Fig 5E&I).  These 228 
results indicate that efficient cell-surface expression of AdipoR1 and AdipoR2 is required for 229 
adiponectin signal transduction. 230 
4.  Discussion 231 
In the current report we have elaborated the molecular details governing differential cell-232 
surface expression and downstream coupling of the adiponectin receptors, AdipoR1 and 233 
AdipoR2.  We show that serum starvation increases cell-surface expression of both AdipoR1 234 
and AdipoR2 and that, in contrast to serum from WT mice, serum from mice lacking 235 
adiponectin fails to reduce receptor cell-surface expression consistent with receptor 236 
internalisation.  We also demonstrate that the temporal signal transduction profiles differ for 237 
AdipoR1 and AdipoR2.  Furthermore, we show that these differences are intrinsically 238 
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coupled to their cell-surface expression profiles and their non-conserved, N-terminal trunks 239 
which appear to contain multiple regions that promote or reduce cell-surface expression 240 
respectively. 241 
Previously, we reported that AdipoR1, but not AdipoR2, interacted with ERp46 via its non-242 
conserved N-terminal trunk (Charlton et al., 2010).  Further investigations revealed that the 243 
non-conserved N-terminal trunks of AdipoR1 and AdipoR2 also dictated the cell-surface 244 
expression of AdipoR1 and AdipoR2, with robust cell-surface expression of AdipoR1 but not 245 
AdipoR2 observed under steady-state conditions in CHO cells (Keshvari et al., 2013).  To 246 
address the impact of this difference on coupling to downstream signalling events we first 247 
characterised the effects of serum starvation followed by serum replacement on cell-surface 248 
expression of the receptors.  Serum withdrawal resulted in increased expression of both 249 
AdipoR1 and AdipoR2 although AdipoR2 still exhibited significantly lower cell-surface 250 
expression than AdipoR1.  The addition of serum or gAd reduced cell-surface expression of 251 
both receptors and microscopy suggested that this decrease reflected classic ligand-dependent 252 
internalisation consistent with a previous report (Almabouada et al., 2013).  Our findings 253 
using serum from wild-type and adiponectin KO mice suggest that, at least under these 254 
experimental conditions, no other circulating factors, such as members of the CTRP family 255 
(Schaffler and Buechler, 2012), are able to promote internalisation of the adiponectin 256 
receptors.   257 
Since the seminal discovery of the adiponectin receptors by Kadowaki and colleagues 258 
(Yamauchi et al., 2003) a large body of evidence has accumulated which indicates that 259 
adiponectin-stimulated activation of intracellular signalling pathways via the adiponectin 260 
receptors is highly variable across cell-types and tissues (Hickman and Whitehead, 2012).  261 
The precise mechanisms for this variability remain relatively poorly understood but a number 262 
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of factors are likely to contribute.  For example, the expression levels of AdipoR1 and 263 
AdipoR2 differ across tissues and cell-types (Yamauchi et al., 2003) as do the expression 264 
levels of proteins that have been shown to interact with the receptors and modulate 265 
downstream signalling (Heiker et al., 2010).  Moreover, the adiponectin receptors exhibit 266 
different binding properties (Yamauchi et al., 2003) and investigators have used a range of 267 
different recombinant multimeric or globular forms of adiponectin (Hickman and Whitehead, 268 
2012).  Whilst all of these factors are likely to contribute to differential activation of 269 
intracellular signalling pathways it is also noteworthy that relatively few studies have 270 
characterised signalling emanating specifically from AdipoR1 and AdipoR2 under tightly 271 
controlled conditions making this an area where our understanding remains particularly 272 
rudimentary.  Moreover, inspection of the literature reveals several major caveats.  For 273 
example, in the original report from Yamauchi and colleagues AdipoR2 was identified by 274 
sequence homology to AdipoR1 and this probably explains why a truncated form lacking the 275 
non-conserved N-terminal trunk was cloned and characterised (Yamauchi et al., 2003).  We 276 
previously reported that a similar truncated construct exhibits increased cell-surface expression, 277 
compared with full-length AdipoR2 (Keshvari et al., 2013), and, in light of the current findings, 278 
we predict that it would also show altered signalling profiles although this remains to be 279 
determined. 280 
In the present report we used gAd to investigate signalling mediated via AdipoR1 or AdipoR2 281 
constructs in HEK293 cells.  This recombinant form of adiponectin has been used widely by 282 
others, as it represents a more homogenous, less variable product than full-length multimeric 283 
adiponectin (Hickman and Whitehead, 2012) whilst HEK293 cells have been shown to be a 284 
suitable cell model for investigations into adiponectin signalling (Lee et al., 2008).  Interestingly, 285 
and in contrast to the findings from Lee and colleagues (Lee et al., 2008), we were unable to 286 
detect endogenous adiponectin receptors in our parental (non-transfected) HEK293 cells and, 287 
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consistent with this, we did not observe any response upon treatment with gAd in the parental 288 
cells.  As expected however, transfection of AdipoR1 or AdipoR2 conferred sensitivity to gAd.  289 
We found that acute (15 min) coupling to Akt was similar between AdipoR1 and AdipoR2 under 290 
conditions where cell-surface expression of AdipoR1 was typically three-fold higher than for 291 
AdipoR2.  Moreover, sensitivity of AdipoR2-mediated Akt phosphorylation was significantly 292 
greater than that for AdipoR1 after chronic (24 h) treatment, indicating far-greater longevity of 293 
the AdipoR2 signal.   These results were, at least to some extent, recapitulated when coupling to 294 
ERK and p38MAPK was analysed.  For both, AdipoR1-mediated phosphorylation peaked at 15 295 
min whilst AdipoR2-mediated phosphorylation peaked at 24 h.  To our knowledge, this is the 296 
first time such differences in the temporal profiles of adiponectin signalling emanating from 297 
AdipoR1 and AdipoR2 have been described.   298 
Detailed analysis of a series of chimeric receptors revealed that the differential cell-surface 299 
expression of AdipoR1 and AdipoR2 was defined by multiple regions within the non-conserved 300 
N-terminal trunks indicating that no single motif underpinned the observed differences.  301 
Moreover, functional investigations revealed that the temporal signalling profiles were also 302 
determined by these non-conserved N-terminal trunks. 303 
Two motifs (D(x)3LL and F(x)3F(x)3F) were previously reported to play a role in anterograde 304 
trafficking of AdipoR1 (Juhl et al., 2012).  We demonstrated that these motifs are conserved 305 
within the juxtamembrane region of AdipoR2 and are required for the efficient cell-surface 306 
expression of both receptors.  We found that mutation of either of these motifs inhibited cell-307 
surface expression and adiponectin-stimulated phosphorylation of Akt, ERK and p38MAPK.  308 
These data further highlight the importance of efficient cell-surface expression of AdipoR1 309 
and AdipoR2 for efficient downstream signalling and the complexity of adiponectin receptor 310 
trafficking.  Further work is required to elaborate the molecular details governing the 311 
contribution of the non-conserved N-terminal trunks and the conserved sequence motifs 312 
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(including D(x)3LL and F(x)3F(x)3F) and how these, in turn, contribute to the temporal 313 
signalling profiles of AdipoR1 and AdipoR2 respectively. 314 
Adiponectin and its receptors are recognised as attractive potential targets for the treatment of 315 
cardiometabolic disease (Hickman and Whitehead, 2012).  In the current report we have 316 
increased our understanding of processes governing cell-surface expression of the 317 
adiponectin receptors and demonstrate that efficient cell-surface expression is required to 318 
afford sensitivity to adiponectin.  We have established that the non-conserved, N-terminal 319 
trunks of AdipoR1 and AdipoR2 serve as key determinants of the cell-surface expression and 320 
signalling profiles of the receptors.  This work provides a foundation for future studies that 321 
may aim to enhance adiponectin sensitivity by increasing cell-surface expression of the 322 
receptors, particularly AdipoR2. 323 
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6.  Figure legends 415 
Fig.  1.  Effects of serum starvation on cell surface expression of AdipoR1 and AdipoR2.  416 
(A) Flow cytometry and (B) plate-based analysis of HEK293 cells transiently expressing 417 
AdipoR1-HA and AdipoR2-HA constructs.  The cell-surface expression (CSE) ratio shows 418 
the (A) percentage of transfected cells expressing AdipoR1 or AdipoR2 at the cell-surface 419 
and (B) the ratio of cell-surface to total receptor levels   Results are from four independent 420 
experiments (*p<0.05).  (C-J) immunofluorescent microscopy of transiently expressed 421 
AdipoR1-HA or AdipoR2-HA constructs (green) in permeabilised or non-permeabilised 422 
CHO cells with or without 16 h serum starvation.  Plasma membrane is counterstained with 423 
sodium potassium ATPase antibody (red) and nuclei with DAPI (blue).   424 
Fig.  2.  Adiponectin reduces the cell-surface expression of AdipoR1 and AdipoR2.  Flow 425 
cytometry analysis of cell-surface expression ratio of HEK293 cells transiently transfected 426 
with (A) AdipoR1-HA or (B) AdipoR2-HA.  Cells were incubated with fetal bovine serum 427 
(FC) for 0, 30, 60, 120, 240 min or with serum from wild-type mice (WT) or serum from 428 
adiponectin knockout mice (KO) or with gAd (2.5 µg/ml) for 30 min.  The % MAX 429 
represents receptor cell-surface expression in cells without any addition and was set to 100% 430 
for AdipoR1 and AdipoR2 respectively.  Results are from four independent experiments 431 
(*p<0.05).  (C-J) immunofluorescent microscopy of AdipoR1-HA and AdipoR2-HA 432 
constructs transiently expressed in CHO cells following 0, 30, 60 or 120 min treatment with 433 
serum.  Plasma membrane is counterstained with sodium potassium ATPase antibody (red) 434 
and nuclei with DAPI (blue).   435 
Fig.  3.  AdipoR1 and AdipoR2 exhibit different temporal activation profiles.  Western 436 
blot showing levels of (A) AdipoR1 and (B) AdipoR2 in transfected and parental (non-437 
transfected) HEK293 cells.  Alphascreen analysis of (C) Akt, (D) ERK and (E) P38MAPK 438 
phosphorylation in HEK cells transiently expressing AdipoR1 or AdipoR2 constructs 439 
incubated with 2.5 µg/ml globular adiponectin (gAd) for 0, 15 min or 24 h.  Alphascreen 440 
analysis of Akt, ERK and P38MAPK phosphorylation in HEK cells transiently expressing 441 
AdipoR1 or AdipoR2 constructs incubated with increasing concentrations of gAd (0 to 5 442 
µg/ml) for 15 min (F-H) or 24 h (I-K).  Results are from at least four independent 443 
experiments.  In graphs C-E: *p<0.05, **p<0.01, ***p<0.001, comparing AdipoR1 or 444 
AdipoR2 at different timepoints; #p<0.05, ##p<0.01, ###p<0.001, comparing AdipoR1 vs 445 
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AdipoR2 at the same timepoint;  @p<0.05, comparing AdipoR1 vs parental cells at the same 446 
timepoint.  In graphs F-I: *p<0.05, **p<0.01, ***p<0.001 comparing AdipoR1 vs AdipoR2.   447 
Fig.  4.  The non-conserved, N-terminal domain of AdipoR1 and AdipoR2 regulates cell-448 
surface expression and signal transduction.  (A) schematic representation of generated 449 
chimeric constructs. (B) Flow cytometry analysis of cell-surface expression ratio in HEK 450 
cells transiently expressing WT AdipoR1-HA,  AdipoR2-HA and chimeric constructs, 451 
(AdipoR2(1–43)/R1(32–375)-HA, AdipoR2(1–69)/R1(58–375)-HA, AdipoR2(1–81)/R1(71–375)-HA, 452 
AdipoR1(1–31)/R2(44–386)-HA, AdipoR1(1–57)/R2(70–386)-HA and AdipoR1(1–70)/R2(82–386)-HA).  453 
Alphascreen analysis of (C) Akt, (D) ERK and (E) p38MAPK phosphorylation in HEK cells 454 
transiently expressing chimeric AdipoR2(1–81)/R1(71–375)-HA (R2/R1) or AdipoR1(1–70)/R2(82–455 
386)-HA (R1/R2) constructs incubated with 2.5 µg/ml globular adiponectin (gAd) for 0, 15 456 
min or 24 h.  Results are from at least four independent experiments (*p<0.05).  #comparing 457 
different genes, same timepoint.  $comparing selected gene and parental cells, same 458 
timepoint.   459 
Fig.  5.  F(x)3F(x)3F and D(x)3LL motifs are required for efficient cell surface expression 460 
and signal transduction via AdipoR1 and AdipoR2.  (A) Sequence alignment of the 461 
cytoplasmic N-terminal trunk of AdipoR1 and AdipoR2.  Conserved F(x)3F(x)3F and 462 
D(x)3LL motifs are highlighted (in grey).  (B) Flow cytometry analysis of cell-surface 463 
expression ratio in HEK293 cells transiently expressing WT AdipoR1, the F 121, 125, 129A 464 
(R1-FFF) and D106, L110, L111A (R1-DLL) mutants.  Alphascreen analysis of (C) Akt, (D) 465 
ERK and (E) p38MAPK phosphorylation in HEK cells transiently expressing WT AdipoR1, 466 
R1-FFF or R1-DLL constructs incubated with 2.5 ug/ml gAd for 15 min.  (F) Flow cytometry 467 
analysis of cell-surface expression ratio in HEK293 cells transiently expressing WT 468 
AdipoR2, the F 132, 136, 140A (R2-FFF) and D117, L121, L122A (R2-DLL) mutants.  469 
Alphascreen analysis of (G) Akt, (H) ERK and (I) P38MAPK phosphorylation in HEK293 470 
cells transiently expressing WT AdipoR2, R2-FFF or R2-DLL constructs incubated with 2.5 471 
ug/ml gAd for 24 h.  Results are from at least four independent experiments  (*** p<0.001). 472 
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Human R2  MNEPTENRLGCSRTPEPDIRLRKGHQLDGTRRGDNDSHQGDLEPILEASVLSSHHKKSSEEHEYSDEAPQEDEGFMGMSPL- 81 
Mouse R2  MNEPAKHRLGCTRTPEPDIRLRKGHQLDDTRGSNNDNYQGDLEPSLETPVCSSYYENSPEEPECHDDNSQEDEGFMGMSPL- 81
RAT R2    MNEPTEHRLGCTRTPEPDIRLRKGHQLDDTRGGNNDNHHGDLEPSLETPVCSSYYENSPEELECHDDNSQEDEGFMGMSPL- 81 
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Highlights 
 AdipoR1/R2 exhibit different cell-surface expression and temporal signalling profiles 
 The non-conserved, N-terminal trunks (AdipoR1(1-70) /R2(1-81)) underpin the differences 
 Conserved trafficking motifs are required for cell-surface expression of both receptors 
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